Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

By afschroeder • July 26, 2025

Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk JS, Limketkai B. Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn's Disease of the Pouch. Inflamm Bowel Dis. 2025 Jul 25:izaf146. doi: 10.1093/ibd/izaf146. Epub ahead of print. PMID: 40708501.

Tags: CD of the pouch, clinical response, DGSOM Student, Digestive Diseases, durability, endoscopic response, Publications, ustekinumab, vedolizumab

Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial

May FP, Brodney S, Tuan JJ, Syngal S, Chan AT, Glenn B, Johnson G, Chang Y, Drew DA, Moy B, Rodriguez NJ, Warner ET, Anyane-Yeboa[...]

Integrated behavioral care in general hepatology increases alcohol use disorder treatment in veterans

Perumalswami PV, Cornwell BL, Grau PP, Meyers AC, Jayaram M, Irani S, Wongsirisakul P, Liangpunsakul S, Patel A, DePhilippis D, Liberto J, Szymanski BR, McCarthy[...]

Patient-Reported Barriers to On-Time Surveillance After Successful Endoscopic Eradication of Barrett’s Esophagus Neoplasia: A Multicenter Qualitative Interview Study

Kahn A, Paul MM, Kolb JM, Brown B, Eluri S, Leggett CL, Codipilly DC, Ramirez FC, Iyer PG. Patient-Reported Barriers to On-Time Surveillance After Successful[...]